Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents

Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Dong Z [verfasserIn] Zhang X [verfasserIn] Zhang Q [verfasserIn] Tangthianchaichana J [verfasserIn] Guo M [verfasserIn] Du S [verfasserIn] Lu Y [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2024

Schlagwörter:	antimicrobial peptides anticancer mechanisms drug combination anticancer application peptide nano agents.

Übergeordnetes Werk:	In: International Journal of Nanomedicine - Dove Medical Press, 2018, (2024), Seite 1017-1039
Übergeordnetes Werk:	year:2024 ; pages:1017-1039

Links:	Link aufrufen Link aufrufen Journal toc

Katalog-ID:	DOAJ096000252

Internformat


LEADER	01000naa a22002652 4500
001	DOAJ096000252
003	DE-627
005	20240413135825.0
007	cr uuu---uuuuu
008	240413s2024 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)DOAJ096000252
035			\|a (DE-599)DOAJ8f7e4f0264664fa695200707cf7a31fc
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a R5-920
100	0		\|a Dong Z \|e verfasserin \|4 aut
245	1	0	\|a Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents
264		1	\|c 2024
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents
650		4	\|a antimicrobial peptides
650		4	\|a anticancer mechanisms
650		4	\|a drug combination
650		4	\|a anticancer application
650		4	\|a peptide nano agents.
653		0	\|a Medicine (General)
700	0		\|a Zhang X \|e verfasserin \|4 aut
700	0		\|a Zhang Q \|e verfasserin \|4 aut
700	0		\|a Tangthianchaichana J \|e verfasserin \|4 aut
700	0		\|a Guo M \|e verfasserin \|4 aut
700	0		\|a Du S \|e verfasserin \|4 aut
700	0		\|a Lu Y \|e verfasserin \|4 aut
773	0	8	\|i In \|t International Journal of Nanomedicine \|d Dove Medical Press, 2018 \|g (2024), Seite 1017-1039 \|w (DE-627)537879560 \|w (DE-600)2377464-2 \|x 11782013 \|7 nnns
773	1	8	\|g year:2024 \|g pages:1017-1039
856	4	0	\|u https://doaj.org/article/8f7e4f0264664fa695200707cf7a31fc \|z kostenfrei
856	4	0	\|u https://www.dovepress.com/anticancer-mechanisms-and-potential-anticancer-applications-of-antimic-peer-reviewed-fulltext-article-IJN \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1178-2013 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|j 2024 \|h 1017-1039

Indexfelder

author_variant	d z dz z x zx z q zq t j tj g m gm d s ds l y ly
matchkey_str	article:11782013:2024----::niacrehnssnptnilniacrplctosfniirba
hierarchy_sort_str	2024
callnumber-subject-code	R
publishDate	2024
allfields	(DE-627)DOAJ096000252 (DE-599)DOAJ8f7e4f0264664fa695200707cf7a31fc DE-627 ger DE-627 rakwb eng R5-920 Dong Z verfasserin aut Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents antimicrobial peptides anticancer mechanisms drug combination anticancer application peptide nano agents. Medicine (General) Zhang X verfasserin aut Zhang Q verfasserin aut Tangthianchaichana J verfasserin aut Guo M verfasserin aut Du S verfasserin aut Lu Y verfasserin aut In International Journal of Nanomedicine Dove Medical Press, 2018 (2024), Seite 1017-1039 (DE-627)537879560 (DE-600)2377464-2 11782013 nnns year:2024 pages:1017-1039 https://doaj.org/article/8f7e4f0264664fa695200707cf7a31fc kostenfrei https://www.dovepress.com/anticancer-mechanisms-and-potential-anticancer-applications-of-antimic-peer-reviewed-fulltext-article-IJN kostenfrei https://doaj.org/toc/1178-2013 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2024 1017-1039
spelling	(DE-627)DOAJ096000252 (DE-599)DOAJ8f7e4f0264664fa695200707cf7a31fc DE-627 ger DE-627 rakwb eng R5-920 Dong Z verfasserin aut Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents antimicrobial peptides anticancer mechanisms drug combination anticancer application peptide nano agents. Medicine (General) Zhang X verfasserin aut Zhang Q verfasserin aut Tangthianchaichana J verfasserin aut Guo M verfasserin aut Du S verfasserin aut Lu Y verfasserin aut In International Journal of Nanomedicine Dove Medical Press, 2018 (2024), Seite 1017-1039 (DE-627)537879560 (DE-600)2377464-2 11782013 nnns year:2024 pages:1017-1039 https://doaj.org/article/8f7e4f0264664fa695200707cf7a31fc kostenfrei https://www.dovepress.com/anticancer-mechanisms-and-potential-anticancer-applications-of-antimic-peer-reviewed-fulltext-article-IJN kostenfrei https://doaj.org/toc/1178-2013 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2024 1017-1039
allfields_unstemmed	(DE-627)DOAJ096000252 (DE-599)DOAJ8f7e4f0264664fa695200707cf7a31fc DE-627 ger DE-627 rakwb eng R5-920 Dong Z verfasserin aut Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents antimicrobial peptides anticancer mechanisms drug combination anticancer application peptide nano agents. Medicine (General) Zhang X verfasserin aut Zhang Q verfasserin aut Tangthianchaichana J verfasserin aut Guo M verfasserin aut Du S verfasserin aut Lu Y verfasserin aut In International Journal of Nanomedicine Dove Medical Press, 2018 (2024), Seite 1017-1039 (DE-627)537879560 (DE-600)2377464-2 11782013 nnns year:2024 pages:1017-1039 https://doaj.org/article/8f7e4f0264664fa695200707cf7a31fc kostenfrei https://www.dovepress.com/anticancer-mechanisms-and-potential-anticancer-applications-of-antimic-peer-reviewed-fulltext-article-IJN kostenfrei https://doaj.org/toc/1178-2013 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2024 1017-1039
allfieldsGer	(DE-627)DOAJ096000252 (DE-599)DOAJ8f7e4f0264664fa695200707cf7a31fc DE-627 ger DE-627 rakwb eng R5-920 Dong Z verfasserin aut Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents antimicrobial peptides anticancer mechanisms drug combination anticancer application peptide nano agents. Medicine (General) Zhang X verfasserin aut Zhang Q verfasserin aut Tangthianchaichana J verfasserin aut Guo M verfasserin aut Du S verfasserin aut Lu Y verfasserin aut In International Journal of Nanomedicine Dove Medical Press, 2018 (2024), Seite 1017-1039 (DE-627)537879560 (DE-600)2377464-2 11782013 nnns year:2024 pages:1017-1039 https://doaj.org/article/8f7e4f0264664fa695200707cf7a31fc kostenfrei https://www.dovepress.com/anticancer-mechanisms-and-potential-anticancer-applications-of-antimic-peer-reviewed-fulltext-article-IJN kostenfrei https://doaj.org/toc/1178-2013 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2024 1017-1039
allfieldsSound	(DE-627)DOAJ096000252 (DE-599)DOAJ8f7e4f0264664fa695200707cf7a31fc DE-627 ger DE-627 rakwb eng R5-920 Dong Z verfasserin aut Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents antimicrobial peptides anticancer mechanisms drug combination anticancer application peptide nano agents. Medicine (General) Zhang X verfasserin aut Zhang Q verfasserin aut Tangthianchaichana J verfasserin aut Guo M verfasserin aut Du S verfasserin aut Lu Y verfasserin aut In International Journal of Nanomedicine Dove Medical Press, 2018 (2024), Seite 1017-1039 (DE-627)537879560 (DE-600)2377464-2 11782013 nnns year:2024 pages:1017-1039 https://doaj.org/article/8f7e4f0264664fa695200707cf7a31fc kostenfrei https://www.dovepress.com/anticancer-mechanisms-and-potential-anticancer-applications-of-antimic-peer-reviewed-fulltext-article-IJN kostenfrei https://doaj.org/toc/1178-2013 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2024 1017-1039
language	English
source	In International Journal of Nanomedicine (2024), Seite 1017-1039 year:2024 pages:1017-1039
sourceStr	In International Journal of Nanomedicine (2024), Seite 1017-1039 year:2024 pages:1017-1039
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	antimicrobial peptides anticancer mechanisms drug combination anticancer application peptide nano agents. Medicine (General)
isfreeaccess_bool	true
container_title	International Journal of Nanomedicine
authorswithroles_txt_mv	Dong Z @@aut@@ Zhang X @@aut@@ Zhang Q @@aut@@ Tangthianchaichana J @@aut@@ Guo M @@aut@@ Du S @@aut@@ Lu Y @@aut@@
publishDateDaySort_date	2024-01-01T00:00:00Z
hierarchy_top_id	537879560
id	DOAJ096000252
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ096000252</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413135825.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2024 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ096000252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8f7e4f0264664fa695200707cf7a31fc</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R5-920</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Dong Z</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antimicrobial peptides</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anticancer mechanisms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">drug combination</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anticancer application</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">peptide nano agents.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhang X</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhang Q</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tangthianchaichana J</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Guo M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Du S</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lu Y</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International Journal of Nanomedicine</subfield><subfield code="d">Dove Medical Press, 2018</subfield><subfield code="g">(2024), Seite 1017-1039</subfield><subfield code="w">(DE-627)537879560</subfield><subfield code="w">(DE-600)2377464-2</subfield><subfield code="x">11782013</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2024</subfield><subfield code="g">pages:1017-1039</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8f7e4f0264664fa695200707cf7a31fc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/anticancer-mechanisms-and-potential-anticancer-applications-of-antimic-peer-reviewed-fulltext-article-IJN</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1178-2013</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2024</subfield><subfield code="h">1017-1039</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Dong Z
spellingShingle	Dong Z misc R5-920 misc antimicrobial peptides misc anticancer mechanisms misc drug combination misc anticancer application misc peptide nano agents. misc Medicine (General) Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents
authorStr	Dong Z
ppnlink_with_tag_str_mv	@@773@@(DE-627)537879560
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	R5-920
illustrated	Not Illustrated
issn	11782013
topic_title	R5-920 Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents antimicrobial peptides anticancer mechanisms drug combination anticancer application peptide nano agents
topic	misc R5-920 misc antimicrobial peptides misc anticancer mechanisms misc drug combination misc anticancer application misc peptide nano agents. misc Medicine (General)
topic_unstemmed	misc R5-920 misc antimicrobial peptides misc anticancer mechanisms misc drug combination misc anticancer application misc peptide nano agents. misc Medicine (General)
topic_browse	misc R5-920 misc antimicrobial peptides misc anticancer mechanisms misc drug combination misc anticancer application misc peptide nano agents. misc Medicine (General)
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	International Journal of Nanomedicine
hierarchy_parent_id	537879560
hierarchy_top_title	International Journal of Nanomedicine
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)537879560 (DE-600)2377464-2
title	Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents
ctrlnum	(DE-627)DOAJ096000252 (DE-599)DOAJ8f7e4f0264664fa695200707cf7a31fc
title_full	Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents
author_sort	Dong Z
journal	International Journal of Nanomedicine
journalStr	International Journal of Nanomedicine
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2024
contenttype_str_mv	txt
container_start_page	1017
author_browse	Dong Z Zhang X Zhang Q Tangthianchaichana J Guo M Du S Lu Y
class	R5-920
format_se	Elektronische Aufsätze
author-letter	Dong Z
author2-role	verfasserin
title_sort	anticancer mechanisms and potential anticancer applications of antimicrobial peptides and their nano agents
callnumber	R5-920
title_auth	Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents
abstract	Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents
abstractGer	Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents
abstract_unstemmed	Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
title_short	Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents
url	https://doaj.org/article/8f7e4f0264664fa695200707cf7a31fc https://www.dovepress.com/anticancer-mechanisms-and-potential-anticancer-applications-of-antimic-peer-reviewed-fulltext-article-IJN https://doaj.org/toc/1178-2013
remote_bool	true
author2	Zhang X Zhang Q Tangthianchaichana J Guo M Du S Lu Y
author2Str	Zhang X Zhang Q Tangthianchaichana J Guo M Du S Lu Y
ppnlink	537879560
callnumber-subject	R - General Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
callnumber-a	R5-920
up_date	2024-07-03T17:48:51.888Z
_version_	1803581057284440064
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ096000252</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413135825.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2024 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ096000252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8f7e4f0264664fa695200707cf7a31fc</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R5-920</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Dong Z</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Ziyi Dong,1,2 Xinyu Zhang,1 Qing Zhang,1 Jakkree Tangthianchaichana,1,3 Mingxue Guo,1 Shouying Du,1 Yang Lu1 1Laboratory of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Research and Development Centre in Beijing, CSPC Pharmaceutical Group Limited, Beijing, People’s Republic of China; 3Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, ThailandCorrespondence: Yang Lu; Shouying Du, Beijing University of Chinese Medicine, Number 11 East Section of the North Third Ring Road, Beijing, 100029, People’s Republic of China, Tel + 86-10-84738615, Email luyangbucm.edu.cn; dumenzidi123@163.comAbstract: Traditional chemotherapy is one of the main methods of cancer treatment, which is largely limited by severe side effects and frequent development of multi-drug resistance by cancer cells. Antimicrobial peptides (AMPs) with high efficiency and low toxicity, as one of the most promising new drugs to replace chemoradiotherapy, have become a current research hotspot, attracting the attention of worldwide researchers. AMPs are natural-source small peptides from the innate immune system, and certain AMPs can selectively kill a broad spectrum of cancer cells while exhibiting less damage to normal cells. Although it involves intracellular mechanisms, AMPs exert their anti-cancer effects mainly through membrane destruction effect; thus, AMPs also hold unique advantages in fighting drug-resistant cancer cells. However, the poor stability and hemolytic toxicity of peptides limit their clinical application. Fortunately, functionalized nanoparticles have many possibilities in overcoming the shortcomings of AMPs, which provides a huge prospect for better application of AMPs. In this paper, we briefly introduce the characteristics and different sources of AMPs, review and summarize the mechanisms of action and the research status of AMPs used as an anticancer therapy, and finally focus on the further use of AMPs nano agents in the anti-cancer direction. Keywords: antimicrobial peptides, anticancer mechanisms, drug combination, anticancer application, peptide nano agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antimicrobial peptides</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anticancer mechanisms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">drug combination</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anticancer application</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">peptide nano agents.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhang X</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhang Q</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tangthianchaichana J</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Guo M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Du S</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lu Y</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International Journal of Nanomedicine</subfield><subfield code="d">Dove Medical Press, 2018</subfield><subfield code="g">(2024), Seite 1017-1039</subfield><subfield code="w">(DE-627)537879560</subfield><subfield code="w">(DE-600)2377464-2</subfield><subfield code="x">11782013</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2024</subfield><subfield code="g">pages:1017-1039</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8f7e4f0264664fa695200707cf7a31fc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/anticancer-mechanisms-and-potential-anticancer-applications-of-antimic-peer-reviewed-fulltext-article-IJN</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1178-2013</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2024</subfield><subfield code="h">1017-1039</subfield></datafield></record></collection>
score	7.4012003

Nicht das Richtige dabei?

Schreiben Sie uns!

Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?